跳至主要内容
临床试验/PACTR201211000432357
PACTR201211000432357尚未招募未知

Pre-emptive value of methylpredinsolone intravenous infusion in patients with vertebral deposits. Double blinded randomized study

a0 个研究点目标入组 120 人开始时间: 2012年10月8日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
a
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Year(s) 至 70 Year(s)(—)
性别
All

入选标准

  • : One hundred twenty patients with class I-III Harrington classification of vertebral metastases included in the study admitted to the oncology department

排除标准

  • Patients with any medical contraindications to corticosteroids, such as diabetes mellitus, uncontrolled hypertension, infection, thrombo-embolic disorders or active peptic ulcer were excluded from the study. Patients with a pathological fracture at the irradiated site, patients with other bone metastases and patients with visceral metastases at the time of radiotherapy were also excluded from the study.

研究者

发起方
a

相似试验